Dr. Daniel Dilworth, MD

NPI: 1336219484
Total Payments
$4,785
2024 Payments
$187.24
Companies
34
Transactions
173
Medicare Patients
232
Medicare Billing
$13,301

Payment Breakdown by Category

Food & Beverage$3,485 (72.8%)
Travel$1,272 (26.6%)
Education$27.85 (0.6%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $3,485 167 72.8%
Travel and Lodging $1,272 4 26.6%
Education $27.85 2 0.6%

Top Paying Companies

Company Total Records Latest Year
Covidien LP $1,651 10 $0 (2017)
Gynesonics, Inc. $604.07 2 $0 (2022)
ABBVIE INC. $569.50 48 $0 (2022)
Channel Medsystems, Inc. $299.55 2 $0 (2024)
TherapeuticsMD, Inc. $185.77 13 $0 (2022)
Sumitomo Pharma America, Inc. $185.35 15 $0 (2024)
Agile Therapeutics, Inc. $140.83 7 $0 (2022)
Minerva Surgical, Inc $138.04 4 $0 (2022)
Allergan Inc. $122.57 9 $0 (2019)
Merck Sharp & Dohme LLC $116.45 8 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $187.24 5 Channel Medsystems, Inc. ($111.14)
2023 $194.23 17 Sumitomo Pharma America, Inc. ($142.85)
2022 $1,251 34 Gynesonics, Inc. ($604.07)
2021 $583.83 43 AbbVie Inc. ($147.91)
2020 $192.98 13 AbbVie Inc. ($74.08)
2019 $291.80 19 AbbVie, Inc. ($80.34)
2018 $223.35 17 AbbVie, Inc. ($106.43)
2017 $1,861 25 Covidien LP ($1,651)

All Payment Transactions

173 individual payment records from CMS Open Payments — Page 1 of 7

Date Company Product Nature Form Amount Type
05/25/2024 Channel Medsystems, Inc. Food and Beverage Cash or cash equivalent $111.14 General
03/21/2024 Merck Sharp & Dohme LLC GARDASIL (Biological), GARDASIL 9 Food and Beverage In-kind items and services $17.05 General
Category: VACCINE
03/09/2024 Sumitomo Pharma America, Inc. MYFEMBREE (Drug) Food and Beverage In-kind items and services $22.20 General
Category: HORMONE THERAPY
02/13/2024 Astellas Pharma US Inc Veozah (Drug) Food and Beverage In-kind items and services $16.55 General
Category: Biological
01/27/2024 Sumitomo Pharma America, Inc. MYFEMBREE (Drug) Food and Beverage In-kind items and services $20.30 General
Category: HORMONE THERAPY
12/01/2023 Sumitomo Pharma America, Inc. MYFEMBREE (Drug) Food and Beverage In-kind items and services $7.35 General
Category: HORMONE THERAPY
11/18/2023 Sumitomo Pharma America, Inc. MYFEMBREE (Drug) Food and Beverage In-kind items and services $19.73 General
Category: HORMONE THERAPY
11/03/2023 Sumitomo Pharma America, Inc. MYFEMBREE (Drug) Food and Beverage In-kind items and services $7.16 General
Category: HORMONE THERAPY
10/30/2023 Hologic Sales and Service, LLC ACESSA PROVU SYSTEM (Device) Food and Beverage In-kind items and services $19.59 General
Category: Surgical
10/20/2023 Sumitomo Pharma America, Inc. MYFEMBREE (Drug) Food and Beverage In-kind items and services $7.12 General
Category: HORMONE THERAPY
10/06/2023 Sumitomo Pharma America, Inc. MYFEMBREE (Drug) Food and Beverage In-kind items and services $7.00 General
Category: HORMONE THERAPY
09/15/2023 Sumitomo Pharma America, Inc. MYFEMBREE (Drug) Food and Beverage In-kind items and services $20.64 General
Category: HORMONE THERAPY
07/28/2023 Sumitomo Pharma America, Inc. MYFEMBREE (Drug) Food and Beverage In-kind items and services $7.69 General
Category: HORMONE THERAPY
07/25/2023 Meditrina Food and Beverage Cash or cash equivalent $10.85 General
07/20/2023 Astellas Pharma US Inc Veozah (Drug) Food and Beverage In-kind items and services $15.74 General
Category: Biological
06/30/2023 Sumitomo Pharma America, Inc. MYFEMBREE (Drug) Food and Beverage In-kind items and services $21.65 General
Category: HORMONE THERAPY
06/30/2023 Sumitomo Pharma America, Inc. MYFEMBREE (Drug) Food and Beverage In-kind items and services $17.72 General
Category: HORMONE THERAPY
06/16/2023 Sumitomo Pharma America, Inc. MYFEMBREE (Drug) Food and Beverage In-kind items and services $6.47 General
Category: HORMONE THERAPY
05/19/2023 Sumitomo Pharma America, Inc. MYFEMBREE (Drug) Food and Beverage In-kind items and services $6.79 General
Category: HORMONE THERAPY
04/26/2023 Sumitomo Pharma America, Inc. MYFEMBREE (Drug) Food and Beverage In-kind items and services $7.62 General
Category: HORMONE THERAPY
03/21/2023 MAYNE PHARMA COMMERCIAL LLC NEXTSTELLIS (Drug) Food and Beverage In-kind items and services $5.20 General
Category: CONTRACEPTIVE
03/10/2023 Sumitomo Pharma America, Inc. MYFEMBREE (Drug) Food and Beverage In-kind items and services $5.91 General
Category: HORMONE THERAPY
11/11/2022 Organon LLC NEXPLANON (Drug) Food and Beverage In-kind items and services $6.66 General
Category: ETONOGESTREL
10/28/2022 Channel Medsystems, Inc. Food and Beverage Cash or cash equivalent $188.41 General
09/12/2022 Minerva Surgical, Inc Food and Beverage In-kind items and services $23.89 General
Category: Ablation System

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 2 29 34 $4,394 $1,713
2022 3 60 77 $13,318 $3,617
2021 4 86 96 $12,688 $4,792
2020 4 57 70 $10,435 $3,179
Total Patients
232
Total Services
277
Medicare Billing
$13,301
Procedure Codes
13

All Medicare Procedures & Services

13 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 16 21 $3,360 $1,231 36.6%
G0101 Cervical or vaginal cancer screening; pelvic and clinical breast examination Office 2023 13 13 $1,034 $482.30 46.6%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 23 38 $6,080 $1,714 28.2%
76830 Ultrasound scan of uterus, ovaries, tubes, cervix and pelvic area through vagina Office 2022 14 16 $5,280 $1,073 20.3%
G0101 Cervical or vaginal cancer screening; pelvic and clinical breast examination Office 2022 23 23 $1,958 $830.37 42.4%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 28 38 $6,025 $2,300 38.2%
G0101 Cervical or vaginal cancer screening; pelvic and clinical breast examination Office 2021 29 29 $2,078 $1,049 50.5%
76830 Ultrasound pelvis through vagina Office 2021 11 11 $3,630 $733.26 20.2%
Q0091 Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory Office 2021 18 18 $955.00 $709.92 74.3%
99213 Established patient office or other outpatient visit, typically 15 minutes Office 2020 16 25 $4,000 $1,260 31.5%
76830 Ultrasound pelvis through vagina Office 2020 12 12 $3,960 $886.72 22.4%
G0101 Cervical or vaginal cancer screening; pelvic and clinical breast examination Office 2020 18 18 $900.00 $665.38 73.9%
99212 Established patient office or other outpatient visit, typically 10 minutes Office 2020 11 15 $1,575 $366.95 23.3%

About Dr. Daniel Dilworth, MD

Dr. Daniel Dilworth, MD is a Obstetrics & Gynecology healthcare provider based in Troy, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/08/2006. The National Provider Identifier (NPI) number assigned to this provider is 1336219484.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Dilworth, MD has received a total of $4,785 in payments from pharmaceutical and medical device companies, with $187.24 received in 2024. These payments were reported across 173 transactions from 34 companies. The most common payment nature is "Food and Beverage" ($3,485).

As a Medicare-enrolled provider, Dilworth has provided services to 232 Medicare beneficiaries, totaling 277 services with total Medicare billing of $13,301. Data is available for 4 years (2020–2023), covering 13 distinct procedure/service records.

Practice Information

  • Specialty Obstetrics & Gynecology
  • Location Troy, OH
  • Active Since 11/08/2006
  • Last Updated 07/08/2007
  • Taxonomy Code 207V00000X
  • Entity Type Individual
  • NPI Number 1336219484

Products in Payments

  • V-Loc (Device) $1,584
  • SONATA SONOGRAPHY-GUIDED TRANSCERVICAL FIBROID ABLATION SYSTEM (Device) $604.07
  • LO LOESTRIN FE (Drug) $332.29
  • MYFEMBREE (Drug) $185.35
  • ANNOVERA (Drug) $148.37
  • Twirla (Drug) $140.83
  • NEXPLANON (Drug) $121.15
  • Orilissa (Drug) $100.14
  • Lupron (Drug) $97.90
  • Balcoltra (Drug) $78.65
  • LILETTA (Drug) $68.18
  • ORILISSA (Drug) $64.68
  • Xulane (Drug) $46.51
  • SLYND (Drug) $40.78
  • Methergine (Drug) $33.66
  • Veozah (Drug) $32.29
  • Phexxi (Drug) $30.35
  • TRINTELLIX (Drug) $29.00
  • NUVARING (Drug) $27.13
  • Nitronox (Device) $27.03

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Obstetrics & Gynecology Doctors in Troy